An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Investigational Drug Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Concerns
However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering products of unknown origin.
Some experts said the popularity for the experimental drug could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.
Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate medicines, advertising, and customer laws, potentially leading to fines, legal action or prison.
Service Response and Material Elimination
Based on the social media company, the service has removed problematic material and prohibited related keywords and query recommendations. The organization said it was dedicated to keeping the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with images of weight loss, positive reviews and detailed instructions for mixing or administering at residence.
After minutes of joining one group, a vendor posted contact information, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.
Item Details and Pricing
Inside these communities, posts show black plastic parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how long a injector should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram stated it actively monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her staff has previously seen patients injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may expose patients to possibly significant medical dangers”.
